Myasthenia Gravis Disease
Myasthenia Gravis Disease market is segmented by players, region (country), by Type and by Applic ... Read More
Global Multiple Sclerosis Treatment Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunomodulatory
1.2.3 Immunosuppressive
1.2.4 Interferons
1.2.5 Others
1.3 Market by Sales Channel
1.3.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Multiple Sclerosis Treatment Market Perspective (2017-2028)
2.2 Multiple Sclerosis Treatment Growth Trends by Region
2.2.1 Multiple Sclerosis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Multiple Sclerosis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Multiple Sclerosis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Multiple Sclerosis Treatment Market Dynamics
2.3.1 Multiple Sclerosis Treatment Industry Trends
2.3.2 Multiple Sclerosis Treatment Market Drivers
2.3.3 Multiple Sclerosis Treatment Market Challenges
2.3.4 Multiple Sclerosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Sclerosis Treatment Players by Revenue
3.1.1 Global Top Multiple Sclerosis Treatment Players by Revenue (2017-2022)
3.1.2 Global Multiple Sclerosis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Multiple Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiple Sclerosis Treatment Revenue
3.4 Global Multiple Sclerosis Treatment Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Treatment Revenue in 2021
3.5 Multiple Sclerosis Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Sclerosis Treatment Product Solution and Service
3.7 Date of Enter into Multiple Sclerosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Sclerosis Treatment Breakdown Data by Type
4.1 Global Multiple Sclerosis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2023-2028)
5 Multiple Sclerosis Treatment Breakdown Data by Sales Channel
5.1 Global Multiple Sclerosis Treatment Historic Market Size by Sales Channel (2017-2022)
5.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Sales Channel (2023-2028)
6 North America
6.1 North America Multiple Sclerosis Treatment Market Size (2017-2028)
6.2 North America Multiple Sclerosis Treatment Market Size by Country (2017-2022)
6.3 North America Multiple Sclerosis Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Multiple Sclerosis Treatment Market Size (2017-2028)
7.2 Europe Multiple Sclerosis Treatment Market Size by Country (2017-2022)
7.3 Europe Multiple Sclerosis Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Sclerosis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Multiple Sclerosis Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Multiple Sclerosis Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Multiple Sclerosis Treatment Market Size (2017-2028)
9.2 Latin America Multiple Sclerosis Treatment Market Size by Country (2017-2022)
9.3 Latin America Multiple Sclerosis Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Sclerosis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Multiple Sclerosis Treatment Introduction
11.1.4 Pfizer Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Detail
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Multiple Sclerosis Treatment Introduction
11.2.4 Merck & Co Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.2.5 Merck & Co Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Detail
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Multiple Sclerosis Treatment Introduction
11.3.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.3.5 Teva Pharmaceutical Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Multiple Sclerosis Treatment Introduction
11.4.4 Sanofi Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Multiple Sclerosis Treatment Introduction
11.5.4 Bayer Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.5.5 Bayer Recent Development
11.6 Biogen
11.6.1 Biogen Company Detail
11.6.2 Biogen Business Overview
11.6.3 Biogen Multiple Sclerosis Treatment Introduction
11.6.4 Biogen Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.6.5 Biogen Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Multiple Sclerosis Treatment Introduction
11.7.4 Roche Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.7.5 Roche Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Multiple Sclerosis Treatment Introduction
11.8.4 Novartis Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.8.5 Novartis Recent Development
11.9 CinnaGen
11.9.1 CinnaGen Company Detail
11.9.2 CinnaGen Business Overview
11.9.3 CinnaGen Multiple Sclerosis Treatment Introduction
11.9.4 CinnaGen Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.9.5 CinnaGen Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Multiple Sclerosis Treatment Introduction
11.10.4 Mylan Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.10.5 Mylan Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Multiple Sclerosis Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Janssen Pharmaceuticals
11.12.1 Janssen Pharmaceuticals Company Detail
11.12.2 Janssen Pharmaceuticals Business Overview
11.12.3 Janssen Pharmaceuticals Multiple Sclerosis Treatment Introduction
11.12.4 Janssen Pharmaceuticals Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.12.5 Janssen Pharmaceuticals Recent Development
11.13 Acorda Therapeutics
11.13.1 Acorda Therapeutics Company Detail
11.13.2 Acorda Therapeutics Business Overview
11.13.3 Acorda Therapeutics Multiple Sclerosis Treatment Introduction
11.13.4 Acorda Therapeutics Revenue in Multiple Sclerosis Treatment Business (2017-2022)
11.13.5 Acorda Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunomodulatory
Table 3. Key Players of Immunosuppressive
Table 4. Key Players of Interferons
Table 5. Key Players of Others
Table 6. Global Multiple Sclerosis Treatment Market Size Growth by Sales Channel (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Multiple Sclerosis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Multiple Sclerosis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Multiple Sclerosis Treatment Market Share by Region (2017-2022)
Table 10. Global Multiple Sclerosis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Multiple Sclerosis Treatment Market Share by Region (2023-2028)
Table 12. Multiple Sclerosis Treatment Market Trends
Table 13. Multiple Sclerosis Treatment Market Drivers
Table 14. Multiple Sclerosis Treatment Market Challenges
Table 15. Multiple Sclerosis Treatment Market Restraints
Table 16. Global Multiple Sclerosis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Multiple Sclerosis Treatment Market Share by Players (2017-2022)
Table 18. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment as of 2021)
Table 19. Ranking of Global Top Multiple Sclerosis Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Multiple Sclerosis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Multiple Sclerosis Treatment Product Solution and Service
Table 23. Date of Enter into Multiple Sclerosis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Multiple Sclerosis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Multiple Sclerosis Treatment Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 30. Global Multiple Sclerosis Treatment Revenue Market Share by Sales Channel (2017-2022)
Table 31. Global Multiple Sclerosis Treatment Forecasted Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 32. Global Multiple Sclerosis Treatment Revenue Market Share by Sales Channel (2023-2028)
Table 33. North America Multiple Sclerosis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Multiple Sclerosis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Multiple Sclerosis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Multiple Sclerosis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Multiple Sclerosis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Multiple Sclerosis Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Multiple Sclerosis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Multiple Sclerosis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Pfizer Company Detail
Table 44. Pfizer Business Overview
Table 45. Pfizer Multiple Sclerosis Treatment Product
Table 46. Pfizer Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 47. Pfizer Recent Development
Table 48. Merck & Co Company Detail
Table 49. Merck & Co Business Overview
Table 50. Merck & Co Multiple Sclerosis Treatment Product
Table 51. Merck & Co Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 52. Merck & Co Recent Development
Table 53. Teva Pharmaceutical Company Detail
Table 54. Teva Pharmaceutical Business Overview
Table 55. Teva Pharmaceutical Multiple Sclerosis Treatment Product
Table 56. Teva Pharmaceutical Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 57. Teva Pharmaceutical Recent Development
Table 58. Sanofi Company Detail
Table 59. Sanofi Business Overview
Table 60. Sanofi Multiple Sclerosis Treatment Product
Table 61. Sanofi Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 62. Sanofi Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Multiple Sclerosis Treatment Product
Table 66. Bayer Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Biogen Company Detail
Table 69. Biogen Business Overview
Table 70. Biogen Multiple Sclerosis Treatment Product
Table 71. Biogen Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 72. Biogen Recent Development
Table 73. Roche Company Detail
Table 74. Roche Business Overview
Table 75. Roche Multiple Sclerosis Treatment Product
Table 76. Roche Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Novartis Company Detail
Table 79. Novartis Business Overview
Table 80. Novartis Multiple Sclerosis Treatment Product
Table 81. Novartis Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. CinnaGen Company Detail
Table 84. CinnaGen Business Overview
Table 85. CinnaGen Multiple Sclerosis Treatment Product
Table 86. CinnaGen Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 87. CinnaGen Recent Development
Table 88. Mylan Company Detail
Table 89. Mylan Business Overview
Table 90. Mylan Multiple Sclerosis Treatment Product
Table 91. Mylan Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 92. Mylan Recent Development
Table 93. Bristol-Myers Squibb Company Detail
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Multiple Sclerosis TreatmentProduct
Table 96. Bristol-Myers Squibb Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Janssen Pharmaceuticals Company Detail
Table 99. Janssen Pharmaceuticals Business Overview
Table 100. Janssen Pharmaceuticals Multiple Sclerosis TreatmentProduct
Table 101. Janssen Pharmaceuticals Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 102. Janssen Pharmaceuticals Recent Development
Table 103. Acorda Therapeutics Company Detail
Table 104. Acorda Therapeutics Business Overview
Table 105. Acorda Therapeutics Multiple Sclerosis TreatmentProduct
Table 106. Acorda Therapeutics Revenue in Multiple Sclerosis Treatment Business (2017-2022) & (US$ Million)
Table 107. Acorda Therapeutics Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Treatment Market Share by Type: 2021 VS 2028
Figure 2. Immunomodulatory Features
Figure 3. Immunosuppressive Features
Figure 4. Interferons Features
Figure 5. Others Features
Figure 6. Global Multiple Sclerosis Treatment Market Share by Sales Channel in 2021 & 2028
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Stores Case Studies
Figure 10. Multiple Sclerosis Treatment Report Years Considered
Figure 11. Global Multiple Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Multiple Sclerosis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Multiple Sclerosis Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Multiple Sclerosis Treatment Market Share by Players in 2021
Figure 15. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Multiple Sclerosis Treatment Revenue in 2021
Figure 17. North America Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Multiple Sclerosis Treatment Market Share by Country (2017-2028)
Figure 19. United States Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Multiple Sclerosis Treatment Market Share by Country (2017-2028)
Figure 23. Germany Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Multiple Sclerosis Treatment Market Share by Region (2017-2028)
Figure 31. China Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Multiple Sclerosis Treatment Market Share by Country (2017-2028)
Figure 39. Mexico Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Multiple Sclerosis Treatment Market Share by Country (2017-2028)
Figure 43. Turkey Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Multiple Sclerosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 46. Merck & Co Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 47. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 48. Sanofi Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 49. Bayer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 50. Biogen Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 51. Roche Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 52. Novartis Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 53. CinnaGen Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 54. Mylan Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 56. Janssen Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 57. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Treatment Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Merck & Co Teva Pharmaceutical Sanofi Bayer Biogen Roche Novartis CinnaGen Mylan Bristol-Myers Squibb Janssen Pharmaceuticals Acorda Therapeutics